Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

645 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Polarization-Resolved Extreme-Ultraviolet Second-Harmonic Generation from LiNbO_{3}.
Uzundal CB, Jamnuch S, Berger E, Woodahl C, Manset P, Hirata Y, Sumi T, Amado A, Akai H, Kubota Y, Owada S, Tono K, Yabashi M, Freeland JW, Schwartz CP, Drisdell WS, Matsuda I, Pascal TA, Zong A, Zuerch M. Uzundal CB, et al. Among authors: sumi t. Phys Rev Lett. 2021 Dec 3;127(23):237402. doi: 10.1103/PhysRevLett.127.237402. Phys Rev Lett. 2021. PMID: 34936786 Free article.
Ultrafast Subpicosecond Magnetization of a 2D Ferromagnet.
Anh LD, Kobayashi M, Takeda T, Araki K, Okano R, Sumi T, Horio M, Yamamoto K, Kubota Y, Owada S, Yabashi M, Matsuda I, Tanaka M. Anh LD, et al. Among authors: sumi t. Adv Mater. 2023 Oct;35(40):e2301347. doi: 10.1002/adma.202301347. Epub 2023 Jul 27. Adv Mater. 2023. PMID: 37309900
Efficacy and safety of nivolumab and ipilimumab with or without chemotherapy for unresectable non-small cell lung cancer: a multicenter retrospective observational study.
Sumi T, Nagano Y, Yokoo K, Ishikawa T, Nishikiori H, Honjo O, Kudo S, Yamazoe M, Kondoh S, Shioya M, Otsuka M, Hashimoto M, Yabe H, Tanaka Y, Sudo Y, Yanagi M, Takahashi M, Chiba H. Sumi T, et al. Cancer Immunol Immunother. 2025 Jan 3;74(2):39. doi: 10.1007/s00262-024-03890-4. Cancer Immunol Immunother. 2025. PMID: 39751674 Free PMC article.
Real-world data of first-line treatment with pembrolizumab for NSCLC with high PD-L1 expression in elderly patients: a subgroup analysis of HOT/NJLCG2001.
Tateishi K, Mizugaki H, Ikezawa Y, Morita R, Yokoo K, Sumi T, Aso M, Kikuchi H, Nakamura A, Sekikawa M, Yoshiike F, Kitamura Y, Kimura N, Hachiya T, Tsurumi K, Agatsuma T, Megumi F, Nakamura K, Jingu D, Yamamoto H, Kosaka M, Yokouchi H. Tateishi K, et al. Among authors: sumi t. Jpn J Clin Oncol. 2024 Dec 4:hyae168. doi: 10.1093/jjco/hyae168. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 39656678
645 results